The Effect of Mergers on Big Pharma

09/02/2011

To cope with projected revenue loss due to increased FDA regulation and blockbuster drugs going off-patent, pharmaceutical companies have consolidated significantly over the past five years. Organizations like Pfizer/Wyeth, Merck/Schering Plough, and Schering Plough/Organon BioSciences have merged forces to improve efficiencies and increase the number of drugs brought to market.